 Liver Neoplasms
"Liver Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the LIVER.
| Descriptor ID |
D008113
|
| MeSH Number(s) |
C04.588.274.623 C06.301.623 C06.552.697
|
| Concept/Terms |
Liver Neoplasms- Liver Neoplasms
- Neoplasms, Hepatic
- Neoplasms, Liver
- Liver Neoplasm
- Neoplasm, Liver
- Hepatic Neoplasms
- Hepatic Neoplasm
- Neoplasm, Hepatic
Cancer of Liver- Cancer of Liver
- Hepatocellular Cancer
- Cancers, Hepatocellular
- Hepatocellular Cancers
- Hepatic Cancer
- Cancer, Hepatic
- Cancers, Hepatic
- Hepatic Cancers
- Liver Cancer
- Cancer, Liver
- Cancers, Liver
- Liver Cancers
- Cancer of the Liver
- Cancer, Hepatocellular
|
Below are MeSH descriptors whose meaning is more general than "Liver Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Liver Neoplasms".
This graph shows the total number of publications written about "Liver Neoplasms" by people in this website by year, and whether "Liver Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1990 | 6 | 7 | 13 | | 1991 | 5 | 9 | 14 | | 1992 | 10 | 5 | 15 | | 1993 | 9 | 8 | 17 | | 1994 | 10 | 7 | 17 | | 1995 | 20 | 14 | 34 | | 1996 | 20 | 9 | 29 | | 1997 | 11 | 7 | 18 | | 1998 | 24 | 10 | 34 | | 1999 | 22 | 10 | 32 | | 2000 | 27 | 7 | 34 | | 2001 | 29 | 7 | 36 | | 2002 | 40 | 20 | 60 | | 2003 | 45 | 12 | 57 | | 2004 | 47 | 22 | 69 | | 2005 | 56 | 24 | 80 | | 2006 | 67 | 13 | 80 | | 2007 | 73 | 18 | 91 | | 2008 | 81 | 8 | 89 | | 2009 | 66 | 16 | 82 | | 2010 | 78 | 17 | 95 | | 2011 | 75 | 13 | 88 | | 2012 | 80 | 10 | 90 | | 2013 | 107 | 13 | 120 | | 2014 | 83 | 12 | 95 | | 2015 | 83 | 10 | 93 | | 2016 | 95 | 19 | 114 | | 2017 | 96 | 10 | 106 | | 2018 | 92 | 15 | 107 | | 2019 | 68 | 10 | 78 | | 2020 | 9 | 0 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Liver Neoplasms" by people in Profiles.
-
Finn RS, Qin S, Ikeda M, Galle PR, Ducreux M, Kim TY, Kudo M, Breder V, Merle P, Kaseb AO, Li D, Verret W, Xu DZ, Hernandez S, Liu J, Huang C, Mulla S, Wang Y, Lim HY, Zhu AX, Cheng AL. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med. 2020 05 14; 382(20):1894-1905.
-
Xu D, Wang Z, Xia Y, Shao F, Xia W, Wei Y, Li X, Qian X, Lee JH, Du L, Zheng Y, Lv G, Leu JS, Wang H, Xing D, Liang T, Hung MC, Lu Z. The gluconeogenic enzyme PCK1 phosphorylates INSIG1/2 for lipogenesis. Nature. 2020 04; 580(7804):530-535.
-
Yu S, Wang Y, Hou J, Li W, Wang X, Xiang L, Tan D, Wang W, Jiang L, Claret FX, Jiao M, Guo H. Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival. PLoS One. 2020; 15(4):e0231003.
-
Cloyd JM, Mizuno T, Kawaguchi Y, Lillemoe HA, Karagkounis G, Omichi K, Chun YS, Conrad C, Tzeng CD, Odisio BC, Huang SY, Hicks M, Wei SH, Aloia TA, Vauthey JN. Comprehensive Complication Index Validates Improved Outcomes Over Time Despite Increased Complexity in 3707 Consecutive Hepatectomies. Ann Surg. 2020 04; 271(4):724-731.
-
DiNorcia J, Florman SS, Haydel B, Tabrizian P, Ruiz RM, Klintmalm GB, Senguttuvan S, Lee DD, Taner CB, Verna EC, Halazun KJ, Hoteit M, Levine MH, Chapman WC, Vachharajani N, Aucejo F, Nguyen MH, Melcher ML, Tevar AD, Humar A, Mobley C, Ghobrial M, Nydam TL, Amundsen B, Markmann JF, Berumen J, Hemming AW, Langnas AN, Carney CA, Sudan DL, Hong JC, Kim J, Zimmerman MA, Rana A, Kueht ML, Jones CM, Fishbein TM, Markovic D, Busuttil RW, Agopian VG. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg. 2020 04; 271(4):616-624.
-
Swierz MJ, Storman D, Riemsma RP, Wolff R, Mitus JW, Pedziwiatr M, Kleijnen J, Bala MM. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases. Cochrane Database Syst Rev. 2020 03 12; 3:CD009498.
-
Swierz MJ, Storman D, Riemsma RP, Wolff R, Mitus JW, Pedziwiatr M, Kleijnen J, Bala MM. Percutaneous ethanol injection for liver metastases. Cochrane Database Syst Rev. 2020 02 04; 2:CD008717.
-
Miller ED, Abu-Sbeih H, Styskel B, Nogueras Gonzalez GM, Blechacz B, Naing A, Chalasani N. Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors. Am J Gastroenterol. 2020 02; 115(2):251-261.
-
Chun YS, Vauthey JN. Response to Comment on "Deleterious Effect of RAS and Evolutionary High Risk TP53 Double Mutation in Colorectal Liver Metastases". Ann Surg. 2020 02; 271(2):e16-e17.
-
Katz TA, Grimm SL, Kaushal A, Dong J, Treviño LS, Jangid RK, Gaitán AV, Bertocchio JP, Guan Y, Robertson MJ, Cabrera RM, Finegold MJ, Foulds CE, Coarfa C, Walker CL. Hepatic Tumor Formation in Adult Mice Developmentally Exposed to Organotin. Environ Health Perspect. 2020 01; 128(1):17010.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|